T. Rowe Price Associates’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-10,900
| Closed | -$294K | – | 2980 |
|
|
2022
Q4 | $294K | Hold |
10,900
| – | – | ﹤0.01% | 2378 |
|
|
2022
Q3 | $196K | Hold |
10,900
| – | – | ﹤0.01% | 2550 |
|
|
2022
Q2 | $135K | Hold |
10,900
| – | – | ﹤0.01% | 2686 |
|
|
2022
Q1 | $145K | Hold |
10,900
| – | – | ﹤0.01% | 2773 |
|
|
2021
Q4 | $170K | Buy |
+10,900
| New | +$170K | ﹤0.01% | 2790 |
|
|
2019
Q4 | – | Sell |
-613,315
| Closed | -$3.19M | – | 2558 |
|
|
2019
Q3 | $3.19M | Sell |
613,315
-473,578
| -44% | -$2.46M | ﹤0.01% | 1453 |
|
|
2019
Q2 | $9.84M | Buy |
1,086,893
+274,745
| +34% | +$2.49M | ﹤0.01% | 1315 |
|
|
2019
Q1 | $19.4M | Buy |
812,148
+1,300
| +0.2% | +$31K | ﹤0.01% | 1178 |
|
|
2018
Q4 | $13.3M | Buy |
810,848
+1,468
| +0.2% | +$24.1K | ﹤0.01% | 1257 |
|
|
2018
Q3 | $21.5M | Buy |
809,380
+134,677
| +20% | +$3.58M | ﹤0.01% | 1207 |
|
|
2018
Q2 | $15.4M | Buy |
674,703
+196,094
| +41% | +$4.48M | ﹤0.01% | 1272 |
|
|
2018
Q1 | $10.2M | Buy |
478,609
+432,113
| +929% | +$9.19M | ﹤0.01% | 1325 |
|
|
2017
Q4 | $588K | Buy |
+46,496
| New | +$588K | ﹤0.01% | 2014 |
|